Saliva test for immune markers in mouth cancer
Part of Cancer clinical trials.
This study looks at whether certain genes and a protein in your saliva can help doctors understand mouth cancer better. It involves providing a saliva sample before starting treatment, and the results may lead to more personalized care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with squamous cell carcinoma of the mouth (oral cavity), not in the throat area.
- Your cancer must not have spread to other parts of the body.
- You must not have had any prior treatment for this cancer, such as surgery, radiation, or chemotherapy.
- You must be able to provide a saliva sample using a swab before starting treatment.
- You must not have an active infection or have taken antibiotics in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in saliva or blood that could help detect oral cancer, gum disease, and cavities earlier. If you have one of these conditions, participating may help improve future diagnosis and treatment.
This study looks for changes in saliva (epigenetic biomarkers) that may help doctors diagnose squamous cell carcinoma in the mouth. You may be asked for saliva samples and usual clinical checks to see whether the test can help with diagnosis, especially before surgery.
This study looks at immune cells and substances in blood, saliva, and stool from people with salivary gland cancer. The goal is to find markers that could help predict how the disease behaves.
This trial studies whether a simple saliva test can help detect oral cancer early in people who have a condition called oral submucous fibrosis (OSMF), which raises the risk of oral cancer. Healthy volunteers and those with OSMF or proven oral cancer are needed.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study looks at how oral cancer develops, from early changes in the mouth to invasive cancer. It may help find better ways to prevent or treat oral cancer. If you are having surgery for oral cancer or have a precancerous mouth condition, you may be able to join.
Hear when a new Oral Squamous Cell Carcinoma (OSCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.